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Abstract In several neurodegenerative diseases and myelin disorders, the degeneration profiles
of myelinated axons are compatible with underlying energy deficits. However, it is presently
impossible to measure selectively axonal ATP levels in the electrically active nervous system. We
combined transgenic expression of an ATP-sensor in neurons of mice with confocal FRET imaging
and electrophysiological recordings of acutely isolated optic nerves. This allowed us to monitor
dynamic changes and activity-dependent axonal ATP homeostasis at the cellular level and in real
time. We find that changes in ATP levels correlate well with compound action potentials. However,
this correlation is disrupted when metabolism of lactate is inhibited, suggesting that axonal
glycolysis products are not sufficient to maintain mitochondrial energy metabolism of electrically
active axons. The combined monitoring of cellular ATP and electrical activity is a novel tool to study




In the vertebrate nervous system, long axons have emerged as the ’bottle neck’ of neuronal integrity
(Coleman and Freeman, 2010; Nave, 2010; Hill et al., 2016). In neurodegenerative diseases, axons
often reveal first signs of perturbation, e.g. spheroids, long before the pathological hallmarks of dis-
ease are seen in neuronal somata, such as large protein aggregates or neuronal cell death. In white
matter tracts, Wallerian degeneration of axons is a carefully regulated program of self-destruction
that upon reaching a threshold leads to rapid calcium-dependent proteolysis of axonal proteins. This
degeneration can be experimentally triggered in different ways, including acute axonal dissection or
by blocking mitochondrial energy metabolism (Coleman and Freeman, 2010; Hill et al., 2016). In
disease situations, the mechanisms leading to axon loss are much less clear. For example, in spastic
paraplegia (SPG), which comprises an entire family of inherited axon degeneration disorders, long
myelinated tracts of the spinal cord are progressively lost. However, virtually none of the subforms
shows a clear link between the primary defect and the later loss of myelinated axons, with the possi-
ble exception of mitochondrial disorders, in which the perturbation of axonal energy metabolism is
assumed to underlie a loss of axonal ATP (Ferreirinha et al., 2004; Tarrade et al., 2006). However,
a disturbed energy balance has never been shown. Similarly, in the equally heterogeneous group of
Charcot-Marie-Tooth (CMT) neuropathies of the peripheral nervous system only a small subset is
caused by mitochondrial dysfunction. In most patients (CMT1A) the primary defect resides in the
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axon-associated myelinating glia (Schwann cells), and it is unknown whether the axonal energy
metabolism is perturbed before the onset of axon degeneration.
Axonal ATP consumption in white matter tracts largely depends on the electric spiking activity
that differs between regions, and it is virtually impossible to biochemically determine ATP selectively
in the axonal compartment and under ’working conditions’ with a high temporal and spatial resolu-
tion. To solve this problem, we have developed a novel approach to simultaneously study action
potential propagation and ATP levels in axons of optic nerves of mice, a white matter tract suitable
for studying axonal energy metabolism (Stys et al., 1991; Saab et al., 2016). We established the
transgenic mouse line ThyAT, in which the fluorescent ATP-sensor ATeam1.03YEMK (Imamura et al.,
2009) shows pan-neuronal expression in vivo. Stimulating electrically optic nerves acutely isolated
from those mice, we combined recordings of compound action potentials (CAP) with confocal imag-
ing of the ATP-sensor to evaluate and compare both axonal conductivity and ATP levels. We find
that (1) axonal glycolysis is not sufficient to robustly sustain CAPs and physiological ATP levels, but
mitochondrial function is needed to provide ATP; (2) during high-frequency propagation of action
potentials, CAPs are a well-suited parameter to estimate axonal ATP levels; (3) lactate metabolism is
essential for the maintenance of axonal ATP levels, and its inhibition severely affects energy homeo-
stasis of myelinated axons.
Results
ATP imaging in optic nerves
The genetically encoded ATP-sensor ATeam1.03YEMK allows FRET-based monitoring of cellular ATP
levels close to real-time (Imamura et al., 2009). We generated transgenic mice for pan-neuronal in
vivo expression of this sensor driven by the murine Thy1.2 promoter (Caroni, 1997). One mouse line
with 21 copies of the transgene [B6-Tg(Thy1.2-ATeam1.03YEMK)AJhi, referred to as ThyAT] displayed
widespread neuronal expression (Figure 1). In the retina, fluorescence marked ganglion cells and
eLife digest The brain contains an intricate network of nerve cells that receive, process, send
and store information. This information travels as electrical impulses along a long, thin part of each
nerve cell known as the nerve fiber or axon. The act of sending these electrical signals requires a lot
of energy, and energy in cells is most often stored within molecules of adenosine triphosphate
(called ATP for short).
Importantly, a better understanding of how the production and consumption of ATP in nerve
cells relates to electrical activity would help scientists to better understand how a shortage of
energy in the brain contributes to diseases like multiple sclerosis. However, to date, it has been
challenging to study the dynamics of ATP in nerve cells that are active.
Now, Trevisiol et al. describe a new system that allows changes in ATP levels to be seen within
active nerve cells. First, mice were genetically engineered to produce a molecule that works like an
ATP sensor only in their nerve cells. This made it possible to visualize the amount of ATP inside the
axons in real-time using a microscope. Measuring ATP levels and recording the electrical signals
moving along an axon at the same time allowed Trevisiol et al. to see how ATP content and
electrical activity correlate and regulate each other.
The experiments reveal that strong electrical activity reduces the ATP content of the axon.
Trevisiol et al. also discovered that nerve cells are unable to generate enough energy on their own
to sustain their electrical activity. These results provide evidence that other cells in the brain – most
likely non-nerve cells called oligodendrocytes – play an active role in delivering energy-rich
substances to the axons of nerve cells.
In the future, the same tools and approaches could be used to monitor ATP levels and electrical
activity in mice that model neurological disorders. Such experiments could tell scientists more about
how disturbing energy production in nerve cells affects these diseases.
DOI: 10.7554/eLife.24241.002
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Figure 1. Characterization of the expression pattern of the newly generated B6-Tg(Thy1.2-ATeam1.03YEMK)AJhi (ThyAT)-mouse line. (A) Sagittal section
of the brain highlights broad ATeam1.03YEMK expression in neurons in almost all brain regions with the exception of the olfactory bulb. Scale bar: 1
mm. (B,C) ThyAT expression pattern in coronal brain sections revealing sensor expression e.g. in thalamus, hypothalamus, amygdala, cortex and
hippocampus. Scale bar: 1 mm. Abbreviations used in panels A–C are: AV: arbor vitae; BLA: basolateral amygdalar nucleus, anterior; CA1: CA1 region
Figure 1 continued on next page
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their axons (Figure 1G,H) and expression of the ATP-sensor in myelinated axons appeared robust in
all recorded channels (Figure 1I–K).
Optic nerves from adult ThyAT mice were studied ex vivo, assessing axonal ATP levels by confo-
cal microscopy and simultaneously monitoring stimulus-evoked CAPs (Figure 2). To verify sensor
function, nerves were subjected to ATP depletion by blocking mitochondrial respiration with sodium
azide (MB) and glucose deprivation (GD). An immediate drop of the FRET signal (Figure 2C,D) and
increase in CFP emission (Figure 2C,D) indicated that ATP levels in axons dropped. Changes in pH
can modulate YFP-fluorescence (Nagai et al., 2004; Zhao et al., 2011). However, ATeam1.03YEMK is
almost insensitive to pH within the physiological range (Imamura et al., 2009; Surin et al., 2014)
and YFP emission upon direct YFP excitation was unchanged (Figure 2C,D; and data not shown),
suggesting that pH changes are not the cause of altered FRET signals.
The ratio of FRET/CFP fluorescence (F/C-ratio) was calculated as a measure for the cytosolic ATP
concentration (Imamura et al., 2009; Figure 2E,F). The baseline F/C-ratio (control condition; 10 mM
glucose) was similar and stable between different nerves analyzed (Figure 2F), while after 2 min of
MB+GD the F/C-ratio was reduced by 35.1 ± 1.7% (p<0.001; n = 19 nerves; Figure 2F). In further
experiments, F/C-ratios were normalized between one (10 mM glucose) and zero (MB+GD;
Figure 2G). As expected, during MB+GD the decrease in axonal ATP was mirrored by a decay of
CAPs, reflecting conduction blocks (Figure 2H). Strikingly, also the decline rates of axonal ATP and
conductivity were similar (Figure 2I).
Kinetics of ATP decline during energy deprivation
Next, we compared ATP and CAP dynamics in response to different modes of energy deprivation
(Figure 3; Figure 3—figure supplement 1), including glucose deprivation (GD), blockage of mito-
chondrial respiration by azide (MB), and a combination of both (MB+GD). During GD both ATP and
CAPs decayed after 13 min (Figure 3A). Inhibition of respiration resulted in a drop after about 3 min
with a steeper decline (Figure 3B). MB+GD induced an immediate and fast decline of ATP, followed
by an equally fast decline in CAPs (Figure 3C–E). To reduce permanent damage and to study recov-
ery, MB and MB+GD were limited to 5 min. The observed change of the ATP sensor signal is most
likely not caused by major changes in pH as YFP fluorescence remained almost unchanged under all
conditions of energy deprivation (Figure 2D and Figure 3—figure supplement 2). These data sug-
gest that optic nerves continue ATP production under GD, presumably by metabolizing glycogen of
astrocytes (Brown et al., 2005). However, axonal ATP production strongly depends on mitochon-
drial respiration, and axonal glycolysis alone is insufficient to maintain ATP levels, even in the virtual
absence of electrical activity (baseline recording conditions with 0.033 Hz stimulation frequency).
When nerves were reperfused (aCSF, 10 mM glucose) after GD, CAPs recovered with a delay of
about 3 min, and the recovery of CAPs preceded the visible recovery of ATP levels by several
minutes (Figure 3A,F). Interestingly, following MB+GD, CAPs recovered significantly sooner, con-
comitantly with axonal ATP, and faster (Figure 3F,G). We presume that, under MB+GD, lactate/
pyruvate was not depleted from the optic nerve and is readily available for ATP generation by mito-
chondria after cessation of MB+GD.
Figure 1 continued
of the hippocampus; cc: corpus callosum; Cf: columns of the fornix; CN: cerebellar nuclei; Cp: cerebral peduncle; CPu: caudate putamen; Fi: fimbria; IC:
inferior colliculus; ic: internal capsule; LH: lateral area of the hypothalamus; M: medulla; opt: optic tract; P: pons; S: subiculum; SC: superior colliculus;
SMA: somato-motor area (cortex); SN: substantia nigra; st: stria terminalis; T: thalamus; Zi: zona incerta (thalamus). (D) Within the cortex, neurons
expressing ATeam1.03YEMK are clearly visible including their processes. Note the lack of ATP-sensor localization to the nucleus. Scale bar: 100 mm. (E)
Also in the hippocampus neurons strongly express ATeam1.03YEMK. Scale bar: 100 mm. (F) In the cerebellum, Purkinje cells express the ATP-sensor. In
addition, incoming mossy fibers strongly express ATeam1.03YEMK. Scale bar: 100 mm. Images in panels A, D–F are obtained on brain slices from a four
month old animal, images in panels B and C are from mice at the age of two month. (G) Expression pattern of the ATP-sensor in the retina. Thy1.2
promoter drives the expression of ATeam1.03YEMK in ganglion cells. Scale bar: 1 mm. (H) Magnified view of neurons and axons in the retina expressing
ATeam1.03YEMK. Scale bar: 100 mm. (I–K) Representative images of optic nerve axons showing the YFP channel (I), FRET channel (J) and CFP channel
(K). The ATeam1.03YEMK expression is present in different axons independent of their diameter. Scale bar: 10 mm.
DOI: 10.7554/eLife.24241.003
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Figure 2. Imaging of ATP combined with electrophysiology in acutely isolated optic nerves of ThyAT-mice. (A) Binding of ATP induces a conformational
change in the genetically encoded ATP-sensor ATeam1.03YEMK thus increasing the FRET effect (YFP emission upon CFP excitation) and simultaneous
decreased emission of CFP (upon CFP excitation). The ratio between FRET and CFP can thus be correlated with the concentration of ATP present in
the cell. (B) Schematic representation of the set-up to acquire evoked CAPs in the optic nerve and to simultaneously investigate relative ATP levels by
electrophysiology and confocal imaging, respectively. (C) Time course of fluorescence intensity recorded in the YFP, FRET and CFP- channels during
application of mitochondrial blockage (MB) and glucose deprivation (GD) for 2.5 min. Values are normalized to YFP intensity prior to application of
MB+GD (n = 3 nerves). Time resolution: 10.4 s. (D) The combination of MB and GD is a fast and reliable way to deplete ATP in axons of the optic nerve.
ATP depletion is measured as a decrease in FRET and increase in CFP, calculated as ratio between fluorophore intensity during MB+GD, over
fluorophore intensity at baseline condition (MB+GD/Baseline). Notably, YFP emission upon YFP excitation remains unchanged (n = 5 nerves). (E)
Ratiometric images displaying the FRET/CFP ratio of the ATeam1.03YEMK–sensor in the axons of the optic nerve during ATP depletion following
MB+GD. The phases before (Baseline) and after (Recovery) are also shown. Scale bar: 10 mm. (F) FRET/CFP ratio values (not normalized) during baseline
and MB+GD. The boxplots show summarized data of n = 19 nerves, lines in between boxplots show changes in the FRET/CFP ratio of all 19 individual
nerves (***p<0.001). (G) To assess ATP variations, the ratio of the fluorescence intensities of the FRET and CFP-channel was calculated (FRET/CFP ratio)
and normalized to baseline (set as 1) and MB+GD (set as 0). The red dashed line visualizes the slope of ATP drop at the point of maximal velocity of
ATP decay during mitochondrial blockage (MB+GD, n = 3). (H) Recording of the evoked compound action potential (CAP), given as the normalized
curve integral during mitochondrial blockage and glucose deprivation (MB+GD). The black dashed line represents the slope at the point of maximal
velocity of CAP changes during MB+GD treatment (n = 3). Individual CAP traces are shown in Figure 3—figure supplement 1. (I) Stripe plot
describing CAP (black) and ATP (red) kinetics, expressed as maximal variation per s, during MB+GD (p=0.39, n = 3, Welch’s t-test). Dots show individual
data points, bars and lines represent the mean of all data.
DOI: 10.7554/eLife.24241.004
The following source data is available for figure 2:
Figure 2 continued on next page
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Electrical activity during high frequency stimulation depletes ATP
Maintaining axonal conductivity ex vivo depends on energy-rich substrates and high- frequency stim-
ulation of axons causes CAPs to decrease (Brown et al., 2001; Tekko¨k et al., 2005). However, it
has never been possible to study the reverse, i.e. the impact of electrical activity and spiking fre-
quency on axonal ATP levels. In ThyAT optic nerves incubated in aCSF containing 10 mM glucose
and subjected to electrical stimulation at 16 Hz, 50 Hz or 100 Hz for 2.5 min, CAPs dropped in a
stimulation frequency dependent manner (16 Hz: 94.9 ± 1.5%; 50 Hz: 79.6 ± 0.4%; 100 Hz: 66.4 ±
1.0%; n = 5 nerves; Figure 4A,C, Figure 4—figure supplement 1). At the same time, axonal ATP
levels decreased as stimulation frequencies increased (16 Hz: 91.6 ± 1.0%; 50 Hz: 82.3 ± 1.4%; 100
Hz: 68.9 ± 2.8%; n = 5 nerves; Figure 4B,D) indicating higher axonal ATP consumption. Even maxi-
mal ATP changes and maximal loss of conductivity correlated over stimulation frequencies
(Figure 4E,F). Similar results were obtained with a different stimulation paradigm with continuously
increasing frequencies (Figure 4—figure supplement 2); however, the causal relations of the corre-
lation of CAP and ATP changes are most likely more complex (see discussion below). Finally, both
the rates of ATP drop and recovery correlated with the amplitude of ATP changes (Figure 4—figure
supplement 3).
ATP homeostasis of myelinated axons depend on lactate metabolism
Next, we asked whether lower (physiological) glucose concentrations have an impact on nerve con-
duction and axonal ATP levels when nerves were challenged with different spiking frequencies
(Figure 4C,D; Figure 4—figure supplement 4). In presence of 10 mM and 3.3 mM glucose, CAP
performance and ATP levels dropped similarly with increasing stimulation frequencies. However,
when only 2 mM glucose was applied both CAP and ATP levels were substantially decreased
(Figure 4C,D) and the ATP/CAP ratio was more variable at 2 mM glucose (Figure 4F). Analysis of
the fluorescence intensity of single channels indicated that the observed changes of the ATP sensor
signal are indeed caused by ATP changes because YFP fluorescence remained rather unaffected
(Figure 4—figure supplement 5). Taken together, these data suggest that 2 mM glucose is below
the threshold required for maintaining the axonal energy balance of the optic nerve in the ex vivo
experimental setting.
At high-frequency stimulation and under aerobic conditions, optic nerve CAPs were maintained
equally well with either 10 mM glucose, 10 mM lactate or 10 mM pyruvate as extracellular energy
substrate (Figure 5A), in agreement with earlier findings (Brown et al., 2001; Tekko¨k et al., 2005)
presumably because absolute axonal ATP consumption is unaffected by the type of metabolic sup-
port. However, at 100 Hz the relative decrease in axonal ATP levels was larger with lactate (or pyru-
vate) than with glucose (glucose: 68.9 ± 2.8%; lactate: 56.3 ± 2.8%; pyruvate: 47.4 ± 2.8%; p=0.05
and p=0.01, respectively; n = 3 nerves; Figure 5B, Figure 5—figure supplement 1), showing that
10 mM glucose maintains axonal ATP production better than 10 mM lactate or pyruvate if applied
exogenously.
Do axons require pyruvate/lactate metabolism also in the presence of glucose as energy sub-
strate? To address this question, we studied optic nerves conduction and ATP levels in 3.3 mM glu-
cose plus 20 mM D-lactate, which competitively inhibits transport through MCTs as well as lactate
dehydrogenase (LDH; D-lactate is a stereoisomer of L-lactate, which is the physiological molecule in
energy metabolism). D-lactate did not affect CAPs (Figure 5C, Figure 5—figure supplement 2) but
had a strong effect on axonal ATP (at 100 Hz: Glc: 59.7 ± 2.9%; Glc+D-Lac: 29.2 ± 2.2%; p=0.0001;
n = 5 nerves; Figure 5D). Similarly, when MCT1/MCT2-mediated lactate transport was inhibited
using the specific inhibitor AR-C155858 (Ovens et al., 2010), relative ATP levels were strongly
reduced (at 100 Hz: 24.8 ± 4.1%; p=0.0004; n = 5 nerves), but with no effect on CAP performance
(at 100 Hz: Glc: 69.5 ± 4.2%; Glc+AR-C155858: 62.8 ± 3.3%; p=0.37; n = 6 nerves; Figure 5C,D; Fig-
ure 5—figure supplement 2), indicating the presence of a ‘safety window’. When lactate metabo-
lism was impaired, ATP/CAP ratios strongly deviated from the normal ‘1:1 ratio’ observed in the
Figure 2 continued
Source data 1. Table containing data for Figure 2.
DOI: 10.7554/eLife.24241.005
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Figure 3. Impairment of axonal ATP and CAP by glucose deprivation and/or inhibition of mitochondrial respiration. (A) Removal of glucose from the
aCSF (glucose deprivation, GD, 45 min) induces similar ATP (red) and CAP (black) decays starting at around 13 min after onset of the treatment. Red
and black dashed, straight lines represent the maximum velocity of ATP and CAP decay (also applies to panels B and C). When 10 mM glucose is
restored, CAP recovery precedes ATP restoration (n = 4 nerves). (B) Blockade of mitochondrial respiration by azide (MB, 5 min) produces a fast decay in
Figure 3 continued on next page
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presence of glucose alone (Figure 5E,F). Collectively, these results strengthen the conclusion that
pyruvate/lactate metabolism is required to maintain ATP levels in fast spiking axons.
Discussion
The axonal energy balance is determined by the equilibrium of ATP consumption and ATP genera-
tion, which is a function of axonal spiking frequency and metabolic support, the latter provided in
part by glycolytic oligodendrocytes (Fu¨nfschilling et al., 2012; Lee et al., 2012; Saab et al., 2016).
Here, we have generated transgenic mice expressing an ATP-sensor in neurons and in the axonal
compartment of myelinated nerves. These mice allowed us to study for the first time the interrela-
tionship of electrical activity and axonal ATP homeostasis in real time by adapting an established
optic nerve model of white matter electrophysiology (Brown et al., 2001; Brown and Ransom,
2007). Specifically, we show that both CAPs and axonal ATP content decrease in a stimulation fre-
quency-dependent manner, and that even in the presence of glucose as (exogenous) energy sub-
strate, lactate contributes to ATP homeostasis. We also analyzed short-term adaptations of
metabolism in a model of ischemic stroke when ATP demands are increased, i.e. the recovery phase
from transient glucose deprivation and mitochondrial inhibition.
While being a powerful experimental system, some caveats need to be taken into account to
interpret the obtained results. First, the signal of the ATeam1.03YEMK sensor is not linearly related to
ATP over an extended range of concentrations (Imamura et al., 2009). However, in cultured neurons
the cytosolic ATP concentration has been estimated at approximately 2 mM (Rangaraju et al.,
2014; Pathak et al., 2015), i.e. within the linear range of ATeam1.03YEMK. We are thus confident
that the observed changes in sensor signal reflect similar relative changes of axonal ATP. However,
as calibration of the ATP-sensor signal to absolute cytosolic concentrations is difficult in the myelin-
ated optic nerve, a precise estimation of the absolute concentration of axonal ATP awaits further
technical advances. Nevertheless, changes of the ATP signal in the course of an experiment could
be detected even after mild stimulations, which suggest that the basal axonal ATP level is within the
dynamic range of the sensor with its KD of 1.2 mM (Imamura et al., 2009).
Secondly, with the spatial resolution of our approach, ATP signals reflect mean cytosolic concen-
trations in the axoplasm. It has been suggested that local differences of ATP consumption by Na+/
K+-ATPase lead to ATP microdomains close to the cell membrane with low ATP concentrations
(Haller et al., 2001; Toloe et al., 2014). Contrarily, ATP diffusion is reported to be very fast not
allowing formation of ATP microdomains (Barros et al., 2013). While such highly localized changes
of ATP would be missed in our experiments, they are unlikely to affect the principle findings.
Figure 3 continued
ATP (red) and CAP (black) starting at 1.8 min after beginning of treatment. When azide is removed, CAP and ATP are promptly restored, with CAP
recovery preceding the ATP increase (n = 4 nerves). (C) Simultaneous removal of glucose and blockade of mitochondrial respiration with azide (MB
+GD, 5 min) produces a fast decay in ATP (red) preceding CAP decay (black), starting already 0.5 min after onset of treatment. Following azide removal
and replenishment of glucose, CAP and ATP are restored (n = 4 nerves). (D) Time of onset of the ATP or CAP decay. The slowest decay induction was
observed during glucose deprivation. (E) Velocity of signal decay for ATP and CAP during each of the three treatments: glucose deprivation (GD),
mitochondrial blockage (MB) and the combination of both (MB+GD). (F) Time of onset of ATP or CAP recovery after reperfusion with control aCSF
containing 10 mM glucose. (G) Rate of recovery of both ATP and CAP during reperfusion of the nerves with aCSF containing 10 mM glucose after the
treatments indicated. (H) Comparison of ATP and CAP area overall recovery after individual treatments. Data in D–H is presented as stripe plots, with
dots representing individual data points, bars and lines showing the mean. Hash signs indicate statistically significant differences between ATP and
CAP under the same condition (#p<0.05, ##p<0.01, paired t-test); asterisks on red (ATP) and black (CAP) lines indicate statistically significant differences
between different conditions (*p<0.05, **p<0.01, ***p<0.001; one-way ANOVA with Newman-Keuls post-hoc test).
DOI: 10.7554/eLife.24241.006
The following source data and figure supplements are available for figure 3:
Source data 1. Table containing data for Figure 3.
DOI: 10.7554/eLife.24241.007
Figure supplement 1. Example of progression of CAP traces’ decay during energy deprivation.
DOI: 10.7554/eLife.24241.008
Figure supplement 2. Analysis of fluorescence changes of the ATP sensor during application of different models of energy deprivation to optic nerves.
DOI: 10.7554/eLife.24241.009
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Figure 4. Comparison of ATP and CAP dynamics during high frequency stimulation. (A) The CAP area decreases over time during high-frequency
stimulation (HFS). The decay amplitude deviates from the absence of HFS, indicated by the dashed line (0.1 Hz, used for normalization to 1.0), and
increases progressively with the increase in stimulation frequency (16 Hz, 50 Hz, 100 Hz). Traces from one representative nerve incubated in aCSF
containing 10 mM glucose are shown. (B) Axonal ATP levels also decrease with increasing stimulation frequency, reaching a new steady state level
Figure 4 continued on next page
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Finally, CAPs recorded with supra-threshold stimulation reflect the summation of action potential
propagation of virtually all axons within the optic nerve. In contrast, ATP imaging was performed on
a single optical plane close to the surface of the nerve comprising typically around 30 axons. There-
fore, the observed ATP signals are likely not representative for all axons, as the diffusion of sub-
strates into the core of the nerve may be less efficient than to axons closer to the surface. Our
attempts to address this issue by 2-photon laser scanning microscopy deeper within the nerve have
failed so far, due to scattering occurring in a densely packed and fully myelinated optic nerve (ASS,
unpublished observation). Taking such an inside-out gradient of increasing perfusion efficacy into
account, our approach is presently the best possible approximation of the simultaneous monitoring
of both parameters. Thus, we are not yet able to assign absolute ATP concentrations to physiologi-
cal properties of spiking axons. However, we can readily (i) monitor ATP changes as a function of
axonal spiking activity, (ii) compare metabolites, (iii) assess the role of disease-causing mutations on
axonal conduction and energy metabolism, also under physiological challenge, and finally (iv) study
selected drugs and nutrients in axonal energy metabolism to explore treatment strategies.
Monitoring axonal ATP homeostasis
Targeting the energy producing biochemical pathways by the withdrawal of glucose (GD), blocking
mitochondrial respiration (MB), or both (MB+GD), rapidly reduced axonal ATP content, as expected.
In GD, ATP fell after 13 min, consistent with the utilization of astroglial glycogen as a reserve fuel
(Brown and Ransom, 2007). In contrast, MB caused an immediate drop in ATP. In all conditions,
ATP decreases preceded or coincided with CAP decay, confirming that energy depletion causes
axonal failure (but see caveat above). Interestingly, after GD in the subsequent recovery phase with
glucose, the restoration of ATP levels appeared delayed compared to the recovery of conduction.
We therefore suggest that at the beginning of reperfusion most newly generated ATP is consumed
by Na+/K+-ATPases for reestablishing ion gradients and conduction before it accumulates in the
axon and binds to the ATP-sensor.
Astrocytes can mobilize glycogen and generate lactate to support axonal energy homeostasis
(Brown et al., 2001, 2003, 2005). However, it has been a long-standing debate whether neuronal
Figure 4 continued
which depends on the stimulation frequency. Same experiment as in panel A. (C) Remaining CAP area at the end of the HFS (overall decay amplitude)
during incubation of nerves in different glucose concentrations quantified during the last 30 s of HFS. The stripe plot shows summarized data from
n = 5, 5, or 4 nerves for 10 mM, 3.3 mM and 2 mM glucose, respectively. The dashed line at 1 shows CAP size at 0.1 Hz stimulation frequency, which
was used for normalization. (D) Quantification of ATP decay amplitude during incubation of the same nerves as in (C) in different glucose
concentrations. The dashed line at 1 shows ATP levels at 0.1 Hz stimulation frequency. (E) Correlation of the amplitude of ATP and CAP decay during
HFS of nerves bathed in aCSF containing the glucose concentrations indicated. Data points are very close to the diagonal of the graph indicating that
ATP and CAP change by similar factors. (F) Ratio of ATP and CAP drop during HFS in the presence of glucose in the concentrations indicated. If both
parameters change by the same factor, this ratio remains equal to one. Data in (C–D) is presented as stripe plots, with dots representing individual data
points and bars and lines showing the mean. Asterisks indicate statistically significant differences between glucose concentrations (*p<0.05, ***p<0.001;
Welch’s t-test).
DOI: 10.7554/eLife.24241.010
The following source data and figure supplements are available for figure 4:
Source data 1. Table containing data for Figure 4.
DOI: 10.7554/eLife.24241.011
Figure supplement 1. Example of progression of CAP traces’ decay during high frequency stimulation (HFS).
DOI: 10.7554/eLife.24241.012
Figure supplement 2. Stimulation of optic nerves with progressively increasing frequencies.
DOI: 10.7554/eLife.24241.013
Figure supplement 3. Correlation of the rates and amplitudes of CAP and ATP changes during HFS in different glucose concentrations.
DOI: 10.7554/eLife.24241.014
Figure supplement 4. Example of CAP traces before and after high-frequency stimulation (HFS) of optic nerves incubated in aCSF with different
concentrations of glucose.
DOI: 10.7554/eLife.24241.015
Figure supplement 5. Analysis of fluorescence changes of the ATP sensor during high-frequency stimulation (HFS) of optic nerves incubated in aCSF
with different concentrations of glucose.
DOI: 10.7554/eLife.24241.016
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Figure 5. Energy metabolism of optic nerves depends on the type and concentration of substrates and involves lactate metabolism. (A) The
comparison between CAP area decay of optic nerves incubated in 10 mM glucose aCSF (n = 5 nerves) versus optic nerves incubated either in 10 mM
lactate or 10 mM pyruvate (n = 3 nerves) during HFS, shows no significant differences among the three substrates (p>0.05, Welch’s t test). (B) In
contrast, analysis of axonal ATP levels shows that at higher frequencies glucose is a better substrate to maintain axonal ATP levels. Same experiments
Figure 5 continued on next page
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compartments prefer glucose or lactate as energy-rich substrates (Pellerin and Magistretti, 2012;
Dienel, 2012; Nave, 2010; Hirrlinger and Nave, 2014). In the optic nerve, glucose and pyruvate/
lactate can sustain CAP propagation. We found that axonal ATP levels were significantly lower dur-
ing HFS when nerves were incubated with lactate or pyruvate as the sole energy substrate. This sug-
gests that lactate/pyruvate alone does not support ATP production as well as glucose and confirms
observations in cultured cerebellar granule cells with repetitive activation of NMDA-receptors
(Lange et al., 2015).
Nevertheless, lactate metabolism contributes to axonal energy homeostasis, even in the presence
of glucose, as evidenced by blocking lactate metabolism with D-lactate or AR-C155858. In the pres-
ence of these inhibitors, ATP decreased more strongly than CAP (Figure 5E,F), suggesting the pres-
ence of a ‘safety window’. It also breaks the striking correlation of ATP and CAP observed under
control conditions (Figures 4E,F and 5E,F). One possible explanation is that changes in CAP are
related to ATP consumption, while inhibition of lactate transport affects ATP production. Since the
axonal stimulation protocol is unchanged, also the consumption of ATP should be similar in the pres-
ence of inhibitors of lactate metabolism. Therefore, the inhibition of lactate metabolism impairs ATP
production and causes a lower steady-state level of ATP, but the consumption rates during HFS
remain the same.
Furthermore, this finding suggests that ‘endogenous’ lactate (i.e. produced from glucose) is more
efficient than lactate provided in the medium. One possibility is that glucose enters the nerve more
rapidly than lactate, because glucose transporter expression is optimized in comparison to MCT1.
Moreover, glucose and glycolysis intermediates are readily shuttled via gap junctional coupling
between astrocytes and oligodendrocytes, with lactate being generated also close to the periaxonal
space, whereas exogenous lactate has a more complex path of diffusion involving mostly extracellu-
lar space (Hirrlinger and Nave, 2014). We note that from an evolutionary point of view, such optimi-
zation of glucose utilization is of advantage for the brain, because the liver always aims at
generating a constant blood glucose level, even under starvation conditions.
Taken together, combining ATP imaging and electrophysiology, we demonstrate that metabolic
imaging is a very sensitive analysis tool for real-time monitoring of axonal energy homeostasis and
the underlying neuron-glia interactions in electrically active fiber tracts. Applied to models of dis-
eases this technology will be able to detect subtle perturbations of axonal energy homeostasis and
allow addressing the hypothesis that energy deficits are an early and most likely causal event for
neurodegeneration.
Figure 5 continued
as in panel A. (C) In the presence of glucose (3.3 mM; n = 5 nerves) as exogenous energy substrate, inhibition of lactate metabolism by D-lactate (20
mM; competitive inhibitor of endogenous L-lactate metabolism at MCTs and LDH, n = 6) or AR-C155858 (10 mM; MCT1 and MCT2 selective inhibitor,
n = 6) does not significantly affect CAPs. (D) Analysis of ATP under the same conditions as in (C): ATP levels undergo a strong decrease at higher
frequencies in the presence of D-lactate or AR-C155858. (n = 5 nerves for all conditions). The dashed lines in panels A–D at 1 show CAP size or ATP
levels at 0.1 Hz stimulation frequency used for normalization. (E) Inhibition of metabolism of endogenously produced L-lactate in the presence of
glucose as the sole exogenous energy substrate shifts the correlation of ATP and CAP to the upper left showing that ATP changes more strongly than
CAP. (F) The ratio of ATP and CAP drop decreases significantly in the presence of inhibitors of lactate metabolism, confirming that ATP changes more
strongly than CAP. Asterisks in (A–D and F) indicate significant differences among conditions: *p<0.05, **p<0.01, ***p<0.001; Welch’s t test.
DOI: 10.7554/eLife.24241.017
The following source data and figure supplements are available for figure 5:
Source data 1. Table containing data for Figure 5.
DOI: 10.7554/eLife.24241.018
Figure supplement 1. Correlation of the amplitudes of CAP and ATP changes in the presence of lactate and pyruvate as exogenous energy substrates.
DOI: 10.7554/eLife.24241.019
Figure supplement 2. Example of CAP traces before and after high-frequency stimulation (HFS) of optic nerves in the presence of inhibitors of lactate
metabolism.
DOI: 10.7554/eLife.24241.020




Animals were treated in accordance with the German Protection of Animals Act (TSchG §4 Abs. 3),
with the guidelines for the welfare of experimental animals issued by the European Communities
Council Directive 2010/63/EU as well as the regulation of the institutional ‘Tierschutzkommission’
and the local authorities (T04/13, T20/16; Landesdirektion Leipzig, LAVES Niedersachsen).
Transgenic mice
Animals were bred in the animal facility of the Max-Planck-Institute for Experimental Medicine as
well as the Medical Faculty of the University of Leipzig. Mice were housed in a 12 hr/12 hr light dark
cycle with access to food and water ad libitum. The transgene construct was assembled in pTSC
(Hirrlinger et al., 2005) containing Thy1.2 promoter sequences. The plasmid pDR-GW AT1.03YEMK
(Bermejo et al., 2010) containing the open reading frame of the ATP-sensor ATeam1.03YEMK
(Imamura et al., 2009) was obtained from Wolf Frommer (via Addgene; plasmid #28004). The open
reading frame of ATeam1.03YEMK was subcloned into the XhoI restriction site of pTSC using PCR.
The linearized transgene was injected into fertilized mouse oocytes of the C57BL/6J mouse strain.
Transgenic founders were identified using PCR-based genotyping on genomic DNA isolated from
tail tips (primer 1: 5’-CGCTGAACTTGTGGCCGTTTACG-3’; primer 2: 5’-TCTGAGTGGCAAAGGACC
TTAGG-3’). The mouse line has been registered at the RRID Portal (https://scicrunch.org/resources;
RRID:MGI:5882597).
Determination of copy number
Mouse genomic DNA was isolated from tail biopsies of four C57BL/6J and six ThyAT-mice with Invis-
orb Spin Tissue Mini Kit according to the manufacturer’s instructions (Stratec Biomedical, Birkenfeld,
Germany). Short FAM-labeled hydrolysis probes (UPL) were used for qPCR reactions (Roche Diag-
nostics GmbH, Mannheim, Germany). Primers and the UPL-probe were designed by ProbeFinder
version 2.50 for Mouse (Roche Diagnostics; Primer Thy1s: TGCCGGTGTGTTGAGCTA; Thy1as: TGG
TCCTGTGTTCATTGCTG; UPL 60; amplicon 73 bp). The genomic sequence of Nrg1 was used to cali-
brate for the amount of DNA (Primer Nrg1s: GGCTATAATGCTAACACAGTCCAA; Nrg1as: AG
TGGATCGTAACAACACTGTCA; UPL 38; amplicon 61 bp) as described (Besser et al., 2015). 10 to
25 ng of genomic DNA was subjected to qPCR amplification to measure the amount of Thy1.2 on a
Light Cycler 480 system (Roche Diagnostics) according to the manufacturer’s instructions. The copy
number of the Thy1.2-ATeam1.03YEMK transgene was calculated using the DDCt method compared
to wild type mice carrying only the two endogenous alleles of the Thy1 gene (Besser et al., 2015).
Analysis of the sensor expression pattern
Adult mice were transcardially perfused with 4% formaldehyde solution (PFA, in phosphate buffered
saline: 137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.4) under deep anesthe-
sia. The brain and the eyes were removed and post-fixed for 24 hr in the same fixative. 45 mm thick
sections were cut on a vibratome (Leica VT1000 S, Nussloch, Germany) and slices were mounted
directly after cutting with Vectashield embedding medium (Vectashield HardSet Mounting Medium,
Vector Laboratories, Burlingame, CA, USA). From the eyes, retinal whole mounts were prepared.
For imaging of fixed brain slices and retina, confocal images were acquired on a LSM Olympus
IX71 inverted microscope using an UPlanFL 10x/0.3 objective (Olympus, Hamburg, Germany) for
overview images (Figure 1A–C,G) or an UApo/340 40x/1.35 oil objective (Olympus) for detailed
images (Figure 1D–F,H), respectively. Microscopic images were acquired and processed using
Olympus Software Fluoview v5.0. ATeam1.03YEMK sensor fluorescence was excited with a 488 nm
argon laser and detected through a BA 510–540 nm emission filter (AHF Analysentechnik AG, Tu¨bin-
gen, Germany). For all images, a Kalman filter of two was used for denoising and images were
acquired with 1024  1024 resolution (pixel size for overview images: 0.9 mm; pixel size for detail
images: 0.35 mm). Z-stacks comprise 12–38 singles z-planes for overview images and 30–85 z-planes
for detailed images, respectively, with distances between each z-plane of 2 mm (overview), 0.5 mm
(Figure 1D–F) and 0.35 mm (Figure 1H). Single z-stacks were converted to maximum intensity pro-
jections (by using Fiji macro ‘Flattening V2f.ijm’; generously provided by Jens Eilers; Jens-Karl.
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Eilers@medizin.uni-leipzig.de) and for overview images maximum intensity projections of different
positions (210 for Figure 1A; 154 for Figure 1B; 160 for Figure 1C; 49 for Figure 1G) were stitched
by using Fiji software and a Fiji stitching plugin (Preibisch et al., 2009).
Optic nerve preparation and electrophysiological recordings
For optic nerve experiments, mice were used in an age of 8 to 12 weeks. Optic nerves were excised
from decapitated mice, placed into an interface perfusion chamber (Harvard
Apparatus, Holliston, MA) and continuously superfused with artificial cerebrospinal fluid (aCSF). The
perfusion chamber was continuously aerated by a humidified gas mixture of 95% O2/5% CO2 and
experiments were performed at 37˚C. Custom-made suction electrodes back-filled with aCSF were
used for stimulation and recording as described (Stys et al., 1991; Saab et al., 2016). The stimulat-
ing electrode, connected to a battery (Stimulus Isolator 385; WPI, Berlin, Germany) delivered a
supramaximal stimulus of 0.75 mA to the nerve evoking compound action potentials (CAP). The
recording electrode was connected to an EPC9 amplifier (Heka Elektronik, Lambrecht/
Pfalz, Germany). The signal was amplified 500 times, filtered at 30 kHz, and acquired at 20 kHz or
100 kHz. Before recording, optic nerves were equilibrated for at least 30 min in the chamber.
The CAP, elicited by the maximum stimulation of 0.75 mA, was recorded at baseline stimulation
frequency at 0.1 Hz. During HFS a burst-stimulation was applied consisting of 100 stimuli at the
given frequency (16, 50 or 100 Hz), separated by 460 ms, during which the CAP was recorded; HFS
overall duration was 150 s, independent of the frequency.
Imaging
Live imaging of optic nerves was performed using an up-right confocal laser scanning microscope
(Zeiss LSM 510 META/NLO, Zeiss, Oberkochen, Germany) equipped with an Argon laser and a 63x
objective (Zeiss 63x IR-Achroplan 0.9 W). The objective was immersed into the aCSF superfusing the
optic nerve. Theoretical optical sections of 1.7 mm over a total scanned area of 66.7 mm x 66.7 mm
(512  512 pixels) of the optic nerve were obtained every 10.4 s in three channels, referred as CFP
(excitation 458 nm; emission 470–500 nm), FRET (Ex 458 nm; Em long pass 530 nm) and YFP (Ex 514
nm; Em long pass 530 nm).
Solutions
Optic nerves were superfused by aCSF containing (in mM): 124 NaCl, 3 KCl, 2 CaCl2, 2 MgSO4, 1.25
NaH2PO4, and 23 NaHCO3, which was continuously bubbled with carbogen (95% O2/5% CO2). This
solution was substituted with the appropriate energy substrates as indicated for which the solution
containing 10 mM glucose served as the standard solution in respect to pH and osmolarity. For glu-
cose deprivation (GD), glucose was removed from the aCSF and substitute by sucrose (Merck
Millipore, Darmstadt, Germany) to maintain the correct osmolarity. For mitochondrial blockage
(MB), aCSF containing 10 mM glucose was supplemented with 5 mM sodium azide (Merck Millipore).
For the combination of MB+GD glucose was substituted by sucrose and 5 mM sodium azide was
added.
For HFS, aCSF was supplemented with different substrates. Glucose (Fluka
BioChemika, Munich Germany) was used at three concentrations: 10 mM, 3.3 mM and 2 mM. L-lac-
tate and pyruvate (Sigma-Adrich, Munich, Germany) were used at 10 mM. Inhibitors of lactate
metabolism were added to a basal concentration of glucose of 3.3 mM: the MCT1 inhibitor AR-
C155858 (Med Chem Express, Sollentuna, Sweden) was used at 10 mM; sodium D-lactate (Sigma-




Optic nerve function was monitored quantitatively as the area under the supramaximal CAP. The
CAP area is proportional to the total number of excited axons and represents a convenient and reli-
able means of monitoring optic nerve axon function (Stys et al., 1991; Saab et al., 2016). CAP was
expressed as area under the CAP wave form in a range of approximately 1.5 ms, defined by the
beginning of the response (typically at 0.2 ms after the stimulus) and approximately the end of the
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second peak of the CAP wave form, thereby analyzing the first and second peak characteristic of the
optic nerve evoked CAP. These two peaks are indicative for the large and medium-sized axons
within the optic nerve, which are those that will mainly be resolved by confocal imaging of the ATP
sensor expressed in axons. During high frequency action potential propagation, amplitudes of CAP
peaks generally decrease, while peak latencies increase. The measured CAP area integrates these
two functional changes of nerve conduction. It is, therefore, a parameter well suited to quantify over-
all functional changes of the optic nerve. Data were normalized to the mean obtained during the ini-
tial 15 min (defined as baseline, i.e. no experimental condition applied). Results from several nerves
were pooled, averaged, and plotted against time.
ATP
The relative amount of ATP in the optic nerve was calculated in two steps. Initially, the mean inten-
sity of FRET and CFP channel were extracted from the imaging time-series (in Fiji) and the ratio F/C
was calculated. All fibers visible in the field of view were included within the analysis without any
prior selection. The F/C ratio was then normalized to zero using the F/C value obtained by applica-
tion of MB+GD at the end of each experiment, i.e. by depleting all axons from ATP. Furthermore, F/
C values obtained during baseline recordings in 10 mM glucose at the beginning of each experiment
were set to one. In all experiments, YFP fluorescence upon direct excitation of YFP was analyzed in
parallel. Importantly, YFP fluorescence intensity remained stable throughout the experiments sug-
gesting that the observed changes of the F/C ratio are most likely not due to artificial modulation
e.g. by changes in intra-axonal pH.
ATP and CAP parameters
For GD, MB and MB+GD conditions, m coefficients for the slope-intercepts at the point of maximal
change of the signal were used to calculate the CAP and ATP rate per second, during the initial
decay and the recovery following reperfusion with aCSF containing 10 mM glucose. The time of the
start of decay/recovery of the ATP and CAP curves were defined as the first time-point at which the
slope-intercept of the signal was above a threshold value based on the standard deviation calculated
at the baseline. For HFS analysis three parameters were considered for both CAP and ATP: (1) the
overall amplitude obtained by averaging the data at the time points within the last 15 s of the stimu-
lation (2) the rate of initial decay defined within the 45 s that followed the beginning of the stimula-
tion (3) the rate of recovery defined within the 60 s that followed the end of the stimulation. Rates
were calculated from the m coefficients for the slope-intercepts in the defined time-range.
Presentation of data
All data are presented either as mean ± s.e.m. or as stripe plots showing all data points and the
mean (line within the plot). The number of optic nerves analyzed for each condition is given as n. As
for no condition both optic nerves of one animal were used, the number of nerves is equal to the
number of animals analyzed for each condition. If not indicated otherwise in the figure legends, data
were statistically evaluated using Welch’s t-test and assuming a normal distribution (*p<0.05;
**p<0.01; ***p<0.001).
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